Proteins were expressed in transfected human HEK cells as previously described (Arestrm and others2012)
Proteins were expressed in transfected human HEK cells as previously described (Arestrm and others2012). of mAbs. They further demonstrate the general use of peptide-tagged chimeric proteins as a powerful and straightforward method for efficient mapping of conformational epitopes. == Introduction == Human interferon (hIFN)- is usually predominantly produced by T cells and natural killer (NK) cells, activated by immune and inflammatory stimuli, and promotes both protective innate and adaptive immune responses. It is, however, also involved in various immunopathological conditions and aberrant levels of IFN- are associated with a number of autoinflammatory and autoimmune diseases (Jager and others2010; Reinhardt and others2015). Neutralizing antibodies to hIFN- are therefore interesting as potential therapeutic reagents (Reinisch and others2010; Hatterer and others2012). Mature monomeric hIFN- is usually 143 amino acids long with 2 N-linked glycosylation sites at positions 25 and 97; the fully glycosylated protein is the predominant form. Under physiological conditions, 2 IFN- chains self-associate noncovalently to a homodimer. The dimeric Nidufexor nature of the protein has been confirmed by X-ray crystallography showing that IFN- is usually primarily helical, with each monomer consisting of 6 alpha-helices (A-F) connected by short loops (Fig. 1A; Ealick and others1991; Rabbit Polyclonal to Akt Walter and others1995). The dimer is usually formed when the C-terminal helices (E and F) from one chain associate head-to-tail with the N-terminal helices A, B, C, and D from the other chain. == FIG. 1. == Structure of IFN- and human-bovine IFN- chimeras.(A)Schematic drawing of the IFN- homodimer with helical regions shown as cylinders interconnected by nonhelical sequences shown as thin tubes. The respective monomers are indicated by dark and lightgraywith the pointed part of each helix pointing toward the C terminus. The physique was drawn using the program CN3D (www.ncbi.nlm.nih.gov/Structure/CN3D/cn3d.shtml) based on X-ray chrystallography data for bIFN- (Randal and Kossiakoff,2000), which is very similar to hIFN-.(B)The aligned amino acid sequences of hIFN- and bIFN- are Nidufexor shown with helical regionsboxedand denoted A through F. Chimeric constructs A-F and the nonhelical CT from bIFN- were based on hIFN- with the respective regions substituted with the corresponding bIFN- sequence. The sequence shown does not include the signal peptide. The alignment was made using Clustal W (www.ch.embnet.org/software/ClustalW.html; Larkin and others2007). Symbols represent amino acids with identical (*), comparable (:), or partly similar (.) side chains; below highly different amino acids, no symbol is usually shown. Amino acids shown by X-ray crystallography to interact with IFNGR1 are underlined (Thiel and others2000) as is the KRKRS motif in CT implicated in receptor conversation (Dbeli and others1988). IFN, interferon. The IFN- receptor is Nidufexor usually expressed on most cells and is composed of 2 chains. Following binding of IFN-, the high affinity subunit IFN- receptor alpha chain 1 (IFNGR1) interacts with the smaller subunit IFNGR2, which is required for IFN- signaling (Bach and others1997). Signaling occurs via Janus kinase 1 (Jak1), Jak2, and signal transducer and activator of transcription 1 (STAT1) that after phosphorylation forms homodimers, which translocate inside the nucleus and initiate gene transcription (Bach and others1997). The helical IFN- regions A and B and their connecting loop and helix F interact with the IFN- receptor (Lundell and Narula1994; Thiel and others2000). An evolutionary conserved part of the C terminus (CT) has also been implicated in Nidufexor the receptor conversation but this has not been confirmed by X-ray crystallography due to the flexible.